{"disease":{"id":"tear-film-insufficiency","name":"Tear film insufficiency","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":14,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"ciclosporin","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"Ciclosporin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":68,"revenue":"1866.0","mechanism":""},{"drug_id":"cyclosporine","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"cyclosporine","company_name":"Novartis AG (originally Sandoz)","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"Calcineurin inhibitor (immunosuppressant)","quality_score":67,"revenue":"1866.0","mechanism":"Calcineurin inhibitor that suppresses T-cell activation by blocking IL-2 transcription, preventing organ transplant rejection."},{"drug_id":"polysorbate-80","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Polyethoxylated Sorbitan Monooleate","generic_name":"POLYSORBATE 80","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"crospovidone","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Povidone","generic_name":"CROSPOVIDONE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Antiseptic [EPC]","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"ciclosporine","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ciclosporine","company_name":"Hospices Civils de Lyon","drug_phase":"phase_3","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"lutein","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xanthophyll","generic_name":"LUTEIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":31,"revenue":null,"mechanism":""},{"drug_id":"polyvinyl-alcohol","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vinyl Alcohol Polymer","generic_name":"POLYVINYL ALCOHOL","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Polyvinyl alcohol works by forming a protective barrier on the surface of the eye to help repair and maintain the tear film."},{"drug_id":"terbutaline","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"diquafosol","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Up4U","generic_name":"DIQUAFOSOL","company_name":"Santen Pharmaceutical","drug_phase":"marketed","molecular_target":"P2Y purinoceptor 2","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"neoral","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neoral","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cyclosporin","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cyclosporin","company_name":"Karolinska University Hospital","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"macrogol","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miralax","generic_name":"Macrogol","company_name":"Braintree","drug_phase":"marketed","molecular_target":"","drug_class":"Osmotic Laxative [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"xiidra","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xiidra","company_name":"Qilu Pharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"Integrin alpha-L/beta-2, Intercellular adhesion molecule 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lifitegrast","indication_name":"Tear film insufficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xiidra","generic_name":"LIFITEGRAST","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Intercellular adhesion molecule 1","drug_class":"Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]","quality_score":48,"revenue":null,"mechanism":"Xiidra works by blocking the interaction between immune cells and the surface of the eye, reducing inflammation and promoting tear production."}],"pipeline":[],"offLabel":[],"totalMarketed":14,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03652415","title":"DRy Eye Outcome and Prescription Study","phase":"","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT06860659","title":"Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":84,"lead_sponsor_name":"Department of Medical Services Ministry of Public Health of Thailand","has_results":false},{"nct_id":"NCT03815539","title":"Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Jin Yuan","has_results":false},{"nct_id":"NCT02510235","title":"Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Dompé Farmaceutici S.p.A","has_results":true},{"nct_id":"NCT05549713","title":"The Effect of Upper Blepharoplasty on Vision Quality in the Early Postoperative Period","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Osijek University Hospital","has_results":false},{"nct_id":"NCT03403023","title":"Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Meir Medical Center","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}